Close

Capabilities

FDA and Life Sciences

Regulation has posed increased challenges for the life sciences industry. The emerging role of artificial intelligence and the ongoing change in political landscape continue to create uncertainty in the industry. Our highly regarded FDA and Life Sciences team strategically guides life sciences companies through the entire scope of the evolving framework of FDA and CMS.    We assist our clients on the entire spectrum of FDA-regulated products, including pharmaceuticals, biotech, devices, food, supplements, cosmetics, and tobacco, through all aspects of U.S. and EU regulatory compliance challenges. We draw from decades of industry experience to work through every issue at every stage of a product’s life cycle.

Manufacturers, investors, and other regulated entities value our practical advice and relationships with U.S. state, federal and EU regulatory bodies. The team’s 40+ lawyers and consultants have held senior positions in government, industry, academia and the medical profession. Through benchmarking from over 350 industry clients, our annual marquee conferences, and cutting-edge webinars and client alerts, our attorneys share and analyze key developments and practical insights on the most relevant and novel issues in the life sciences space.

Our regulatory attorneys draw on decades of experience to successfully guide clients through:

  • Clinical trial matters, such as IDE and IND submissions and BIMO inspections
  • Government price reporting obligations and associated commercial and strategic implications
  • FDA approval process and premarket clearance
  • Reimbursement -- coverage, coding and payment
  • FDA requirements and policies applicable to pharma, device, cosmetic, and food labeling and promotion
  • Fraud and abuse compliance, including the FCA, AKS, FCPA, AdvaMed and PhRMA codes, and physician consultant arrangements,
  • FDA inspections, Warning Letters, and administrative litigation (appeals of adverse FDA decisions)
  • Federal Physician Payments Sunshine Act and similar state transparency laws
  • FDA administrative, civil, and criminal enforcement actions
  • Due diligence evaluations on behalf of life sciences companies, private equity funds, and venture capital firms
  • Investigations and all related interactions with FDA, CMS, OIG, and DOJ
  • Complex food regulatory matters and food false advertising litigation

We are distinguished not only by our outstanding attorneys, but also by our industry consultants, including physicians and former senior FDA officials focused on quality and safety, good manufacturing practices, inspections and product approvals. Our consultants work under privileged legal supervision to provide companies with integrated medical and technical assessments and recommendations.

Our team in the EU focuses on EU and national (French, Belgian and German) issues associated with the legal requirements of the pharmaceutical, biologic, medical device, cosmetic and food industries. They advise life sciences clients on successful strategies for addressing significant EU policy developments and the EU regulatory regimes. The EU team represents our clients in litigation cases before German and European courts, including the General Court and the Court of Justice of the European Union, and in investigations.

Read more
Related Lawyers

General Counsel Internal Investigations Decision Tree for the Life Sciences Industry

K&S launches General Counsel Internal Investigations Decision Tree for the Life Sciences industry, including COVID-19 considerations.

explore here

Insights

Newsletter

December 16, 2024
Health Headlines December 16, 2024

Article · Source: American Health Law Association

December 13, 2024
Fulfilling the Promise of Parity

View all

Ranked Tier 1 for FDA: Medical Device


LMG Life Sciences 2024

Ranked Tier 1 for FDA: Pharmaceutical


LMG Life Sciences 2024

2024 FDA Litigation & Enforcement Firm of the Year


LMG Life Sciences

2024 Impact Case of the Year


LMG Life Sciences

Ranked Tier 2 for Life Sciences Industry


Legal 500 2024

Ranked Band 1 for Food & Beverages: Regulatory & Litigation


Chambers USA 2024

Ranked Band 2 Nationwide for Life Sciences: Regulatory/Compliance


Chambers USA 2024

Ranked Band 1 Product Liability & Mass Torts: The Elite


Chambers USA 2024

Ranked Tier 1 (USA Nationwide and DC) for FDA Law


Best Law Firms 2024

LMG Life Sciences named 19 K&S lawyers as “Life Sciences Starts” in the 2024 edition

Four-time winner of Life Sciences Practice Group of the Year


Law360

Practice Group of the Year’ for the Life Sciences Practice


Law360, 2016-2019

Close

Recognition

Ranked Tier 1 for FDA: Medical Device


LMG Life Sciences 2024

Ranked Tier 1 for FDA: Pharmaceutical


LMG Life Sciences 2024

2024 FDA Litigation & Enforcement Firm of the Year


LMG Life Sciences

2024 Impact Case of the Year


LMG Life Sciences

Ranked Tier 2 for Life Sciences Industry


Legal 500 2024

Ranked Band 1 for Food & Beverages: Regulatory & Litigation


Chambers USA 2024

Ranked Band 2 Nationwide for Life Sciences: Regulatory/Compliance


Chambers USA 2024

Ranked Band 1 Product Liability & Mass Torts: The Elite


Chambers USA 2024

Ranked Tier 1 (USA Nationwide and DC) for FDA Law


Best Law Firms 2024

LMG Life Sciences named 19 K&S lawyers as “Life Sciences Starts” in the 2024 edition

Four-time winner of Life Sciences Practice Group of the Year


Law360

Practice Group of the Year’ for the Life Sciences Practice


Law360, 2016-2019